YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...

Amgen's latest once-monthly weight loss drug data looks "OK," analysts say, as its path to approval still remains murky.

The pill version of Novo Nordisk’s blockbuster drug Ozempic ... compared to patients taking a placebo. A sign with the company logo sits on the headquarters campus of Eli Lilly and Company.

Launch of Nipuna Karnataka Logo marked the beginning of a transformative skills initiative. The Karnataka Government signed 6 MoUs with tech companies to bring together global technology leaders to ...

Eventually, Musk reached a deal to acquire the company ... and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet, ...

An array of pharmaceutical pills with the company's logo on the bottle ... while competitor Novo Nordisk charges between DKK 1,313 and 2,353 per month for its weight-loss medication Wegovy.

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK1,025.00. The company’s shares closed yesterday ...

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding ...

Novo Nordisk already has an oral semaglutide to treat type 2 diabetes ... Novo's chief financial officer said in an earnings call that it would source cagrilintide from a third-party company, which ...